The company’s fourth-quarter income was $554 million compared to $564 million a year prior. In 2023, the company is looking for organic revenue growth between 5 and 7 percent, according to a Jan. 30 GE HealthCare news release.
Additionally, the company reported earnings per share of $1.21 compared to $1.24 a year earlier.
“Looking ahead, we’re confident that our accelerated investment in innovation, as well as standardization across platforms, will drive revenue and margin growth,” GE HealthCare President and CEO Peter Arduini said in the release. “We’re seeing customers continue to invest along with macroeconomic tailwinds, such as increasing healthcare digitization, expanding access to care, and an aging population globally. We are well positioned to deliver on our 2023 commitments.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
